Colon cancer blood test offers new screening option
A blood test for colon cancer performed well in a study published Wednesday, offering a new kind of screening for a leading cause of cancer deaths.
The test looks for DNA fragments shed by tumor cells and precancerous growths. It’s already for sale in the U.S. for $895, but has not been approved by the Food and Drug Administration and most insurers do not cover it. The maker of the test, Guardant Health, anticipates an FDA decision this year.
In the study, the test caught 83% of the cancers but very few of the precancerous growths found by colonoscopy, the gold standard for colon cancer screening. Besides spotting tumors, colonoscopies can prevent the disease by removing precancerous growths called polyps.
But some people avoid the exam because of the hassle of getting time off work or the day-ahead preparation that involves drinking a strong laxative to empty the bowels.
Related articles
Lorenzen goes 5 innings in Texas debut as Rangers blank Tigers 1
DETROIT (AP) — Michael Lorenzen pitched five spotless innings in his Texas debut and three relievers2024-05-19Bodies of foreign aid workers transferred to Egypt from Gaza
Bodies of the six foreign aid workers, who were killed in an Israeli strike, have been transferred t2024-05-19Fighter jets fire at targets in live
(China Military Online) 10:12, April 15, 2024A fighter jet attached to a brigade under the PLA Air F2024-05-19Top DPRK leader oversees ground jet test of solid
The top leader of the Democratic People's Republic of Korea (DPRK) oversaw a ground jet test of2024-05-19Death toll in Italy's power plant explosion rises to 5
Two more victims of the explosion at an Italian power station were discovered on Thursday, bringing2024-05-19- The YouTuber who was arrested last week after getting into a physical fight with her boyfriend on a2024-05-19
atest comment